228 related articles for article (PubMed ID: 3790277)
1. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
[TBL] [Abstract][Full Text] [Related]
2. [Sensibility and specificity of N-myc oncogene with respect to other prognostic factors in 15 neuroblastomas].
Queizán A; García-Miguel P; Belló MJ; Castresana JC; Rey JA; Pestaña A
Cir Pediatr; 1995 Jul; 8(3):96-8. PubMed ID: 8527322
[TBL] [Abstract][Full Text] [Related]
3. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
[TBL] [Abstract][Full Text] [Related]
4. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
5. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma.
Nakagawara A; Ikeda K; Higashi K; Sasazuki T
Surgery; 1990 Jan; 107(1):43-9. PubMed ID: 2404349
[TBL] [Abstract][Full Text] [Related]
8. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
[TBL] [Abstract][Full Text] [Related]
9. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H
Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
11. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
12. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P
Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672
[TBL] [Abstract][Full Text] [Related]
13. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
14. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
15. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
16. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy in neuroblastoma.
Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
[TBL] [Abstract][Full Text] [Related]
19. Biological characteristics of N-myc amplified neuroblastoma in patients over one year of age.
Nakagawara A; Ikeda K; Tsuda T; Higashi K
Prog Clin Biol Res; 1988; 271():31-9. PubMed ID: 3406005
[TBL] [Abstract][Full Text] [Related]
20. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
